Enhabit (EHAB) Competitors $8.14 -0.31 (-3.61%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$8.14 +0.01 (+0.06%) As of 02/21/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EHAB vs. NHC, AGL, FTRE, CDNA, VRDN, AHCO, PNTG, AVAH, CSTL, and TALKShould you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include National HealthCare (NHC), agilon health (AGL), Fortrea (FTRE), CareDx (CDNA), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), and Talkspace (TALK). These companies are all part of the "healthcare" industry. Enhabit vs. National HealthCare agilon health Fortrea CareDx Viridian Therapeutics AdaptHealth The Pennant Group Aveanna Healthcare Castle Biosciences Talkspace National HealthCare (NYSE:NHC) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, community ranking, media sentiment and dividends. Is NHC or EHAB more profitable? National HealthCare has a net margin of 10.03% compared to Enhabit's net margin of -11.24%. National HealthCare's return on equity of 6.87% beat Enhabit's return on equity.Company Net Margins Return on Equity Return on Assets National HealthCare10.03% 6.87% 4.68% Enhabit -11.24%1.67%0.80% Which has more risk and volatility, NHC or EHAB? National HealthCare has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.83, indicating that its share price is 83% more volatile than the S&P 500. Which has better earnings and valuation, NHC or EHAB? National HealthCare has higher revenue and earnings than Enhabit. Enhabit is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational HealthCare$1.14B1.27$66.80M$7.9811.74Enhabit$1.04B0.39-$80.50M-$2.32-3.51 Do analysts rate NHC or EHAB? Enhabit has a consensus price target of $8.75, indicating a potential upside of 7.56%. Given Enhabit's stronger consensus rating and higher probable upside, analysts plainly believe Enhabit is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Enhabit 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders & institutionals believe in NHC or EHAB? 56.4% of National HealthCare shares are held by institutional investors. 13.8% of National HealthCare shares are held by company insiders. Comparatively, 1.9% of Enhabit shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer NHC or EHAB? Enhabit received 2 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 14.29% of users gave Enhabit an outperform vote. CompanyUnderperformOutperformNational HealthCareOutperform Votes2100.00% Underperform VotesNo VotesEnhabitOutperform Votes414.29%Underperform Votes2485.71% Does the media refer more to NHC or EHAB? In the previous week, National HealthCare had 2 more articles in the media than Enhabit. MarketBeat recorded 3 mentions for National HealthCare and 1 mentions for Enhabit. Enhabit's average media sentiment score of 0.52 beat National HealthCare's score of 0.01 indicating that Enhabit is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National HealthCare 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Enhabit 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryNational HealthCare beats Enhabit on 12 of the 18 factors compared between the two stocks. Get Enhabit News Delivered to You Automatically Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHAB vs. The Competition Export to ExcelMetricEnhabitHome health care services IndustryMedical SectorNYSE ExchangeMarket Cap$424.40M$3.06B$5.77B$20.07BDividend YieldN/A0.36%4.78%3.65%P/E Ratio-3.5128.8226.4634.91Price / Sales0.391.20453.6915.64Price / Cash3.3817.8044.0420.85Price / Book0.593.377.634.92Net Income-$80.50M-$57.02M$3.18B$1.02B7 Day Performance-6.56%-4.39%-1.91%-1.05%1 Month Performance2.71%-5.89%-0.19%-1.09%1 Year Performance-13.55%24.64%16.70%13.70% Enhabit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHABEnhabit1.5146 of 5 stars$8.14-3.6%$8.75+7.6%-12.5%$424.40M$1.04B-3.5110,800News CoverageNHCNational HealthCareN/A$102.76-0.8%N/AN/A$1.59B$1.23B12.8813,123Dividend AnnouncementAGLagilon health1.3221 of 5 stars$3.43-1.6%$4.03+17.6%-45.0%$1.41B$4.32B-3.641,117Upcoming EarningsNews CoverageFTREFortrea2.5145 of 5 stars$14.97-0.1%$23.30+55.6%-59.1%$1.34B$3.11B-4.3818,000News CoverageCDNACareDx3.7177 of 5 stars$24.50-1.4%$28.33+15.6%+170.5%$1.31B$280.32M-9.07740Upcoming EarningsAnalyst DowngradeNews CoverageVRDNViridian Therapeutics2.8683 of 5 stars$16.40-3.6%$35.70+117.7%-12.1%$1.30B$310,000.00-3.8150AHCOAdaptHealth3.2691 of 5 stars$8.78-1.7%$12.20+39.0%+19.5%$1.18B$3.20B-5.3210,700PNTGThe Pennant Group3.8444 of 5 stars$25.93-2.2%$36.00+38.8%+50.6%$890.70M$544.89M38.135,791AVAHAveanna Healthcare0.4451 of 5 stars$4.60-4.2%$4.51-1.9%+89.9%$888.84M$1.98B-13.5333,500News CoverageCSTLCastle Biosciences2.1173 of 5 stars$27.32-1.1%$40.29+47.5%+4.3%$765.23M$219.79M136.61540News CoveragePositive NewsTALKTalkspace3.6885 of 5 stars$4.08-2.2%$4.38+7.2%+28.6%$689.19M$150.04M-408.00500Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies NHC Competitors AGL Competitors FTRE Competitors CDNA Competitors VRDN Competitors AHCO Competitors PNTG Competitors AVAH Competitors CSTL Competitors TALK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:EHAB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
